Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

Global Gout Therapeutics Market - Analysis, Technologies & Forecast to 2020 - Key Vendors are AstraZeneca, Horizon Pharma & Takeda Pharmaceuticals - Research and Markets

Research and Markets
Posted on: 21 Nov 16

Research and Markets has announced the addition of the "Global Gout Therapeutics Market 2016-2020" report to their offering.

The report forecasts the global gout therapeutics market to grow at a CAGR of 17.16% during the period 2016-2020.

The report has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

The use of regenerative medicine is an emerging treatment option for the treatment of gout. These regenerative medicines help in the healing process by replacement or regeneration of the human cells, tissues or organs, and thus help in establishing the normal function. The various regenerative techniques include cell therapy, growth factor therapy, and others.

According to the report, introduction of novel urate-lowering agents will drive growth in this market. Urate-lowering agents are increasingly becoming the preferred choice of treatment for gout, which will be used as add-on therapy to the existing standard of care and target the gout patients who failed the previous treatment.

Key vendors:

  • AstraZeneca
  • Horizon Pharma
  • Takeda Pharmaceuticals

Key Topics Covered:

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Market research methodology

PART 04: Introduction

PART 05: Gout: Disease overview

PART 06: Pipeline portfolio

PART 07: Market landscape

PART 08: Key buying criteria

PART 09: Market segmentation by drug class

PART 10: Market segmentation by type of disease

PART 11: Geographical segmentation

PART 12: Market drivers

PART 13: Impact of drivers

PART 14: Market challenges

PART 15: Impact of drivers and challenges

PART 16: Market trends

PART 17: Vendor landscape

PART 18: Key vendor analysis

PART 19: Appendix

For more information about this report visit http://www.researchandmarkets.com/research/dh5v2d/global_gout

View source version on businesswire.com: http://www.businesswire.com/news/home/20161121005449/en/

Business Wire
www.businesswire.com

Last updated on: 21/11/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.